Protective Effects of the Phytocystatin CaneCPI-5 on Periodontal Ligament Cell Osteogenic Activity and Alveolar Bone Loss under Inflammatory Challenge

Abstract Periodontal disease is characterized by a chronic inflammatory environment that compromises the regenerative capacity of periodontal tissues, particularly by impairing the osteogenic potential of periodontal ligament cells. Phytocystatins have emerged as bioactive molecules with potential regenerative and immunomodulatory properties; however, their effects on periodontal tissues under inflammatory conditions remain unexplored. In this study, we investigated the effects of CaneCPI-5 on the osteogenic behavior of human periodontal ligament cells (hPDLCs) under basal and inflammatory conditions in vitro, as well as its impact on alveolar bone preservation and periodontal tissue responses in a murine model of experimental periodontitis. In vitro, CaneCPI-5 promoted the expression of osteogenic markers and supported mineralized matrix formation under basal conditions. Notably, CaneCPI-5 preserved osteogenic gene expression and mineral deposition in hPDLCs exposed to Filifactor alocis, indicating a sustained osteogenic response despite inflammatory stimulation. In vivo, treatment with CaneCPI-5 significantly attenuated alveolar bone loss, increased bone mineral density and bone volume fraction, and was associated with histological features indicative of a more preserved periodontal tissue architecture compared with untreated disease controls. Stereometric analyses further revealed reduced inflammatory cell infiltration and vascular density, alongside increased fibroblast presence and extracellular matrix components in treated animals. Collectively, these findings demonstrate that CaneCPI-5 supports osteogenic activity and contributes to periodontal tissue preservation in inflammatory settings. The convergence of in vitro and in vivo data suggests that CaneCPI-5 may be a promising bioactive molecule for the development of adjunctive regenerative strategies to mitigate inflammation-associated periodontal tissue destruction.

Authors

Institutions

Publication Details

Journal
ACS Pharmacology & Translational Science
Published
2026-09-30
DOI
https://doi.org/10.1021/acsptsci.6c00363
Primary Topic
Oral microbiology and periodontitis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Protective Effects of the Phytocystatin CaneCPI-5 on Periodontal Ligament Cell Osteogenic Activity and Alveolar Bone Loss under Inflammatory Challenge

Sigrun Eick, Angélica Letícia Reis Pavanelli, Joni Augusto Cirelli, FLÁVIO HENRIQUE DA SILVA et al.
ACS Pharmacology & Translational Science
Oral microbiology and periodontitis research
article

Protective Effects of the Phytocystatin CaneCPI-5 on Periodontal Ligament Cell Osteogenic Activity and Alveolar Bone Loss under Inflammatory Challenge

Sigrun Eick, Angélica Letícia Reis Pavanelli, Joni Augusto Cirelli, FLÁVIO HENRIQUE DA SILVA, Andressa V. B. Nogueira, James Deschner, Maria Eduarda Scordamaia Lopes, Sâmmea Martins Vieira, Gisele Faria
article en

Abstract

Abstract Periodontal disease is characterized by a chronic inflammatory environment that compromises the regenerative capacity of periodontal tissues, particularly by impairing the osteogenic potential of periodontal ligament cells. Phytocystatins have emerged as bioactive molecules with potential regenerative and immunomodulatory properties; however, their effects on periodontal tissues under inflammatory conditions remain unexplored. In this study, we investigated the effects of CaneCPI-5 on the osteogenic behavior of human periodontal ligament cells (hPDLCs) under basal and inflammatory conditions in vitro, as well as its impact on alveolar bone preservation and periodontal tissue responses in a murine model of experimental periodontitis. In vitro, CaneCPI-5 promoted the expression of osteogenic markers and supported mineralized matrix formation under basal conditions. Notably, CaneCPI-5 preserved osteogenic gene expression and mineral deposition in hPDLCs exposed to Filifactor alocis, indicating a sustained osteogenic response despite inflammatory stimulation. In vivo, treatment with CaneCPI-5 significantly attenuated alveolar bone loss, increased bone mineral density and bone volume fraction, and was associated with histological features indicative of a more preserved periodontal tissue architecture compared with untreated disease controls. Stereometric analyses further revealed reduced inflammatory cell infiltration and vascular density, alongside increased fibroblast presence and extracellular matrix components in treated animals. Collectively, these findings demonstrate that CaneCPI-5 supports osteogenic activity and contributes to periodontal tissue preservation in inflammatory settings. The convergence of in vitro and in vivo data suggests that CaneCPI-5 may be a promising bioactive molecule for the development of adjunctive regenerative strategies to mitigate inflammation-associated periodontal tissue destruction.

ACS Pharmacology & Translational Science
University of Bern (CH), Universidade Federal de São Carlos (BR), Johannes Gutenberg University Mainz (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Universidade Estadual Paulista (Unesp) (BR)
Openalex Percentile: Top 10%
Oral microbiology and periodontitis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.